1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES `
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS
3.1. PARENT MARKET ANALYSIS: MEDICAL DEVICES MARKET
3.2. MARKET DEFINITION
3.3. KEY DRIVERS
3.3.1. INNOVATION IN TECHNOLOGY
3.3.2. RISE IN GERIATRIC POPULATION
3.3.3. REQUIREMENT OF COST REDUCTION IN HEALTHCARE TREATMENTS
3.3.4. GROWING CONCERN OVER CHRONIC WOUNDS
3.3.5. RISE IN THE NUMBER OF DIABETES CASES
3.4. KEY RESTRAINTS
3.4.1. HIGH COST
3.4.2. COMPLICATIONS RELATED TO USE OF NPWT DEVICES
3.4.3. LACK OF TRAINED PROFESSIONALS

4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER'S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
4.5. IMPACT OF COVID-19

5. MARKET BY PRODUCT
5.1. CONVENTIONAL REUSABLE DEVICES
5.2. SINGLE USE DEVICES

6. MARKET BY END-USER
6.1. HOSPITALS & CLINICS
6.2. AMBULATORY SURGICAL CENTERS
6.3. HOME CARE SETTINGS

7. MARKET BY WOUND TYPE
7.1. CHRONIC WOUNDS
7.1.1. PRESSURE ULCER
7.1.2. DIABETIC FOOT ULCER
7.1.3. VENOUS LEG ULCER
7.1.4. ARTERIAL ULCER
7.2. ACUTE WOUNDS
7.2.1. BURNS & TRAUMA
7.2.2. SURGICAL WOUNDS

8. GEOGRAPHICAL ANALYSIS
8.1. EUROPE
8.1.1. UNITED KINGDOM
8.1.2. GERMANY
8.1.3. FRANCE
8.1.4. ITALY
8.1.5. RUSSIA
8.1.6. BELGIUM
8.1.7. POLAND
8.1.8. REST OF EUROPE

9. COMPANY PROFILES
9.1. 3M COMPANY
9.2. CARDINAL HEALTH
9.3. DEROYAL INDUSTRIES INC
9.4. SMITH & NEPHEW PLC
9.5. PAUL HARTMANN AG
9.6. TALLEY GROUP LIMITED
9.7. DEVON INTERNATIONAL GROUP INC
9.8. MĂ–LNLYCKE HEALTH CARE AB
9.9. MEDELA AG
9.10. CONVATEC GROUP PLC